Earn Up to 2 hours of CME!

Zoom Platform 

Pre-Registration is required.

Registration fee: $25.00

Program Description

The goal of this activity is to educate hematology/oncology specialists about the most up-to-date evidence on the use of bruton tyrosine kinase (BTK) inhibitors in patients with B-Cell malignancies, so they can differentiate between agents and can tailor therapy vased on patient- and disease-related factors.